Jacobi J et al. Utilization of research knowledge in sustainable development pathways: Insights from a transdisciplinary research-for-development programme. Environ Sci Policy. 2020;103:21-29. DOI: 10.1016/j.envsci.2019.10.003

Nhung N.T.T et al. Exposure to air pollution and risk of hospitalization for cardiovascular diseases amongst Vietnamese adults: case-crossover study. Sci Total Environ. 2020;703:134637. DOI: 10.1016/j.scitotenv.2019.134637

Pelikan K, Jeffrey R, Roelcke T. The time where the British took the lead is over” - ethical aspects of writing in complex research partnerships. Res Ethics. 2020(in press)

Tasdemir D et al. Antiprotozoal and antihelminthic properties of plants ingested by wild Japanese macaques (Macaca fuscata yakui) in Yakushima Island. J Ethnopharmacol. 2020;247:112270. DOI: 10.1016/j.jep.2019.112270

Abidi S.K et al. An individual patient data meta-analysis to estimate the diagnostic accuracy of a machine learning-based software for analyzing chest x-rays of persons with symptoms of pulmonary tuberculosis: preliminary findings. Am J Respir Crit Care Med, 2019;199:A5167

Ackermann-Liebrich U, Felber Dietrich D, Kutlar Joss M. Respiratory and cardiovascular effects of NO2. Reference Module in Earth Systems and Environmental Sciences, 1-10. Amsterdam: Elsevier, 2019. DOI: 10.1016/B978-0-12-409548-9.02128-X

Ahoua A.R.C et al. Anti-inflammatory and quinone reductase-inducing compounds from Beilschmiedia mannii. Planta Med. 2019;85(5):379-384. DOI: 10.1055/a-0798-3155

Alam M.M et al. Validation of the protein kinase PfCLK3 as a multistage cross-species malarial drug target. Science. 2019;365(6456):eaau1682. DOI: 10.1126/science.aau1682

Alasad S.M.S, Salih O.A.M, Hassan M. Insight into potassium's role in childhood mortality due to severe acute malnutrition. Sudan J Paediatr. 2019;19(1):44-51. DOI: 10.24911/SJP.106-1513711620

Albertini B et al. Combining mechanochemistry and spray congealing for new praziquantel pediatric formulations in schistosomiasis treatment. Int J Mol Sci. 2019;20(5):1233. DOI: 10.3390/ijms20051233

Our research

We are addressing both problems by developing synthetic peptide structures that induce cross-reactive antibodies against the parent malaria proteins and by coupling them to the surface of immunopotentiating reconstituted influenza virosomes (IRIVs). In addition we are evaluating the use of so fare uncharacterized predicted proteins of Plasmodium falciparum as potential new candidate vaccine antigens.

Vaccine Development

One approach is to design a subunit vaccine that incorporates several malaria protein antigens for which there is evidence of protective immunity from epidemiological data or experimental animal challenge models. Development of such subunit vaccines is critically dependent on the availability of an antigen delivery system to drive suitable protein antigen-specific immune responses in humans. Vaccine formulations have to be highly effective, human-compatible and safe. Production of synthetic or recombinant proteins that stably mimic the native structure of the corresponding malaria antigens to induce effective humoral immune responses is a further major challenge.

P. falciparum Malaria: Developing a Synthetic Subunit Candidate Vaccine

Malaria is one of the most serious infectious diseases of humans, infecting 5–10% of the world’s population, with 300–600 million clinical cases and more than 2 million deaths annually. Moreover, malaria is a major social and economic burden in endemic areas. In recent years, malaria has spread at an alarming rate owing to the increasing resistance of the parasite to drugs, and the resistance of mosquitoes to insecticides. Therefore, new approaches to combat malaria are urgently needed, and a vaccine is predicted to have the greatest impact in addition to being the most cost-effective control measure.